Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
PUT
Cintas
CTAS
$81.7B
| $3.05M | ﹤0.01% |
108,400
+58,000
| +115% | +$1.59M |
|
|
JKS
2852
JinkoSolar
JKS
$708M
| $3.05M | ﹤0.01% |
+193,077
| New | +$3.52M |
|
2853
Paychex
PAYX
$45B
| $3.05M | ﹤0.01% |
52,700
-23,642
| -31% | -$1.42M |
|
2854
Belden
BDC
$4.69B
| $3.05M | ﹤0.01% |
44,200
| – | – |
|
2855
CALL
Synopsys
SNPS
$89.1B
| $3.04M | ﹤0.01% |
51,300
+11,300
| +28% | +$642K |
|
|
SODA
2856
PUT
DELISTED
SodaStream International Ltd
SODA
| $3.04M | ﹤0.01% |
114,600
+20,200
| +21% | +$532K |
|
2857
Automatic Data Processing
ADP
$113B
| $3.04M | ﹤0.01% |
34,465
-14,107
| -29% | -$1.28M |
|
2858
CALL
BJ's Restaurants
BJRI
$1.36B
| $3.04M | ﹤0.01% |
85,500
+48,400
| +130% | +$1.95M |
|
2859
PUT
Inovio Pharmaceuticals
INO
$130M
| $3.04M | ﹤0.01% |
27,167
+1,975
| +8% | +$218K |
|
|
HAPN
2860
Happen Inc
HAPN
$2.13B
| $3.03M | ﹤0.01% |
98,199
-91,441
| -48% | -$2.37M |
|
2861
Vanguard Dividend Appreciation ETF
VIG
$113B
| $3.03M | ﹤0.01% |
36,137
-93,461
| -72% | -$7.92M |
|
2862
PUT
Moody's
MCO
$88.2B
| $3.03M | ﹤0.01% |
28,000
-57,000
| -67% | -$5.99M |
|
|
P
2863
CALL
Everpure Inc
P
$33B
| $3.03M | ﹤0.01% |
223,800
-119,500
| -35% | -$1.49M |
|
|
PDCO
2864
CALL
DELISTED
Patterson Companies, Inc.
PDCO
| $3.03M | ﹤0.01% |
66,000
-12,000
| -15% | -$568K |
|
|
CBD
2865
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $3.03M | ﹤0.01% |
184,886
| – | – |
|
2866
CALL
Blackstone Mortgage Trust
BXMT
$2.33B
| $3.02M | ﹤0.01% |
102,700
+89,000
| +650% | +$2.58M |
|
|
INC
2867
DELISTED
ISHARES U S ETF TRFXD INCOME BALANCED RISK ETF (DE)
INC
| $3.02M | ﹤0.01% |
29,842
-6,828
| -19% | -$692K |
|
2868
PUT
Mettler-Toledo International
MTD
$28.2B
| $3.02M | ﹤0.01% |
7,200
+700
| +11% | +$278K |
|
|
PSXP
2869
PUT
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $3.02M | ﹤0.01% |
62,200
-109,800
| -64% | -$5.57M |
|
2870
CALL
PTC Therapeutics
PTCT
$5.99B
| $3.02M | ﹤0.01% |
215,700
+48,900
| +29% | +$398K |
|
2871
PUT
iShares US Transportation ETF
IYT
$2.26B
| $3.02M | ﹤0.01% |
83,200
-171,600
| -67% | -$6.06M |
|
2872
CALL
AES
AES
$10.5B
| $3.02M | ﹤0.01% |
235,000
-185,000
| -44% | -$2.3M |
|
2873
PUT
Vanguard Energy ETF
VDE
$10.6B
| $3.02M | ﹤0.01% |
30,900
-4,700
| -13% | -$446K |
|
|
KRA
2874
CALL
DELISTED
Kraton Corporation
KRA
| $3.02M | ﹤0.01% |
86,100
+70,200
| +442% | +$2.25M |
|
|
KATE
2875
PUT
DELISTED
Kate Spade & Company
KATE
| $3.02M | ﹤0.01% |
176,000
+63,500
| +56% | +$1.23M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.